Increased expression of cytosolic phospholipase A2, 5-lipoxygenase and 5-lipoxygenase-activating protein in rat peritoneal macrophages during ovalbumin-induced sensitization

Clinical and Experimental Allergy

Volumn 31, Issue 7, 2001, Pages 1094-1104

  Escoubet Lozach, L ^a   M'Rini, C ^a,b   Rey, A ^a   Beraud M ^a   Lepert, J C ^a   Courtade, M ^b   Frisach, M F ^a   Pipy, Bernard ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU RANGUEIL   (France)

Author keywords

Allergy; Leukotrienes; Ovalbumin; Rat

Indexed keywords

ALBUMIN; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CALCIMYCIN; CYTOKINE; INTERLEUKIN 4; ISOENZYME; LEUKOTRIENE; OVALBUMIN; PHOSPHOLIPASE A2; TERFENADINE;

ALLERGY; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; CYTOSOL; DIAGNOSTIC TEST; ENZYME MODIFICATION; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPONSE TIME; SENSITIZATION; STIMULATION; WESTERN BLOTTING;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CALCIMYCIN; CARRIER PROTEINS; CELLS, CULTURED; CYTOSOL; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-4; MACROPHAGES, PERITONEAL; MALE; MEMBRANE PROTEINS; OVALBUMIN; PHOSPHOLIPASES A; RATS; RATS, INBRED BN; TETRADECANOYLPHORBOL ACETATE;

EID: 0034824336     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01121.x     Document Type: Article

References (49)

1. Interaction between IgE complexes and macrophages in the rat: A new mechanism of macrophages activation
2. Involvement of IgE in the secretory processes of alveolar macrophages from asthmatic patients
3. The human IgE network
4. Effect of IL-4 on allergen-induced arachidonic acid metabolism of rat peritoneal macrophages during immediate hypersensitivity reactions
5. Secretion of leucotriene C and other AA metabolites by macrophages challenged with IgE immune complexes
6. Leukotrienes and other products of the 5-Lipoxygenase pathway
7. WY-50.295 tromethamine, a novel, orally active 5-LO inhibitor: Biochemical characterization and antiallergic activity
8. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice
9. Properties and purification of an arachidonoyl-hydrolysing PLA2 from a macrophage cell line, RAW 264.7
10. Purification of a 110-kDa cytosolic PLA2 from U937
11. 2
12. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation
13. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages
14. Identification and isolation of a membrane protein necessary for leukotriene production
15. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
16. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells
17. Production of BSF-1 during an in vivo, T-dependant immune response
18. Generation and analysis of interleukin-4 deficient mice
19. Importance of IL-4 and IL-12 in allergen-induced airway changes in mice
20. Human recombinant IL-4 induces Fc receptors (CD23) on normal human B lymphocytes
21. Human recombinant IL-4 induces FcεR2/CD23 on normal human monocytes
22. Two species of human Fcε receptor II (FcεRII/CD23): Tissue-specific and IL-4-specific regulation of gene expression
23. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors
24. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leucocytes
25. Membrane association of active 5-lipoxygenase in resting cells
26. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation
27. Development and transfer of immediate hypersensitivity in mice exposed to aerolized antigen
28. Various immunological phenotypes are associated with increased airway responsiveness
29. Acetylated low density lipoprotein inhibits the incorporation of arachidonic acid in phospholipids with a concomitant increase of cholesterol arachidonate in rat peritoneal macrophages
30. IL-13 induces serine phosphorylation of cPLA2 in mouse peritoneal macrophages leading to arachidonic acid and PGE2 production and blocks the zymosan-induced serine phsophorylation of cPLA2 and eicosanoid production
31. The influence of antigen dose on IgE production in different rat strains
32. Specific and total IgE responses to antigenic stimuli in Brown-Norway, Lewis and Sprague-Dawley rats
33. Airway hyperresponsiveness is associated with inflammation cell infiltration in allergic Brown-Norway rats
34. Expression of Th-2 cytokines IL-4 and -5 and of Th-1 cytokine IFN-γ in ovalbumin-exposed sensitized Brown-Norway rats
35. Alveolar macrophages have greater amounts of the enzyme 5-LO than do monocytes
36. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveaolar macrophages
37. 21-dependant translocation domain with homology to PKC and GAP
38. Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesis
39. cPLA2 is phosphorylated and activated by MAP kinase
40. Discordance between macrophage arachidonate metabolic phenotype and the expression of cPLA2 and cyclooxygenase
41. Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes
42. Regulation of expression of the 5-lipoxygenase pathway
43. Cloning and characterization of a binding subunit of the interleukin-13 receptor that is also a component of the interleukin-4 receptor
44. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors
45. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells
46. Interleukin-13: Central mediator of allergic asthma
47. Requirement for IL-13 independently of IL-4 in experimental asthma
48. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
49. IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages